IMTX Competitors & Alternatives
Compare Immatics NV with similar stocks in the same industry
Biotechnology
IMTX
Main Stock$7.59
Tradestie Score
40
Market Cap
$1.09B
Revenue Growth
0.9%
Analyst Upside
+132.3%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$17.60
|
$1.35B | - | 70 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$32.17
|
$1.32B | - | 57 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$9.08
|
$1.29B | - | 43 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$25.62
|
$1.29B | - | 71 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.34
|
$1.29B | - | 58 | Compare |
|
ZYME
Zymeworks Inc.
|
$25.15
|
$1.28B | - | 60 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$5.14
|
$1.27B | - | 55 | Compare |
|
YDES
YD Bio Limited Ordinary Shares
|
$8.11
|
$1.26B | - | 36 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.35
|
$1.22B | - | 44 | Compare |
More IMTX Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2836)
227 stocks in this industry